1Berry EM,Gupta MM,Turner Sj,et al.Variation in plasma calcium with induced changes in plasma specific gravity,total ptotein,and albumin.Br med J,1973,(4):640-643.
2Payne BB,Little AJ,Williams RB,et al.Corrected calcium coacept.Br Med J,1976,17:153-154.
3lqbal SJ,Giles M,Ledger S,et al.Need albumin adjustments of urgent total serum calcium.The Lancet,1988,24:1477-1478.
4Crawford SM.Hypercalcemia,renal failure,and relapse in multiple myeloma.Cancer, 1985,55:898.
5Greipp PR, Raymond NM, Kyle RA, et aL Multiple myeloma: significance of plasmablastic subtype in morphological classification[J]. Blood, 1985, 65:305 - 310.
6Emest B, Marshall AL Barry SC, et al. Williams Hematology[M]. 5th Ed. 1995. 1109 - 1126.
7Knudsen LM, Hjorth M, Hippe E, et al. Renal failure in multiple myeloma: reversibility and impact on the prognosis[J]. Eur J Haematol,2000, 65(3): 175 - 181.
8Murakami H, Kawada T, Saitoh T, et aL A staging system for multiple myeloma based on the morphology of myeloma cells [J]. Eur J Haematol, 1999, 62:63 - 67.
9Rajkumar SV, Fonseca R, Lacy MQ, et al. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma[J].J Clin Oncol, 1999, 17(5): 1551 - 1557.
10Siegel DS, Desikan KR, Mehta J, et al. Age is not a prognostic variable with autotransplants for multiplemyeloma[J]. Blood, 1999,93(1):51-54.
